시장조사 보고서 : 세계의 펩타이드 기반 약물 시장예측 2021년-2026년

■ 영문 제목 : Global Peptide-based Drug Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02139 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 102 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 펩타이드 기반 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (주사, 경구, 기타)와 용도별 시장규모 (암, 대사성 질환, 중추 신경계, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 펩타이드 기반 약물 시장 점유율
- 지역별 펩타이드 기반 약물 시장규모
- 주요지역의 종류별 시장규모 (주사, 경구, 기타)
- 주요지역의 용도별 시장규모 (암, 대사성 질환, 중추 신경계, 기타)
- 미주의 펩타이드 기반 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 펩타이드 기반 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 펩타이드 기반 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 펩타이드 기반 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 펩타이드 기반 약물 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, J & J
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Peptide-based Drug will have significant change from previous year. By the most conservative estimates of global Peptide-based Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 31480 million in 2020. Over the next five years the Peptide-based Drug market will register a 9.4% CAGR in terms of revenue, the global market size will reach US$ 45060 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide-based Drug market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Injection
Oral
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Cancer
Metabolic Disorders
Central Nervous System
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptide-based Drug Market Size 2016-2026
2.1.2 Peptide-based Drug Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Peptide-based Drug Segment by Type
2.2.1 Injection
2.2.2 Injection
2.2.3 Other
2.3 Peptide-based Drug Market Size by Type
2.3.1 Global Peptide-based Drug Market Size CAGR by Type
2.3.2 Global Peptide-based Drug Market Size Market Share by Type (2016-2021)
2.4 Peptide-based Drug Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Peptide-based Drug Market Size by Application
2.5.1 Global Peptide-based Drug Market Size CAGR by Application
2.5.2 Global Peptide-based Drug Market Size Market Share by Application (2016-2021)

3 Peptide-based Drug Market Size by Players
3.1 Peptide-based Drug Market Size Market Share by Players
3.1.1 Global Peptide-based Drug Revenue by Players (2019-2021E)
3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2019-2021E)
3.2 Global Peptide-based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Peptide-based Drug by Regions
4.1 Peptide-based Drug Market Size by Regions (2016-2021)
4.2 Americas Peptide-based Drug Market Size Growth (2016-2021)
4.3 APAC Peptide-based Drug Market Size Growth (2016-2021)
4.4 Europe Peptide-based Drug Market Size Growth (2016-2021)
4.5 Middle East & Africa Peptide-based Drug Market Size Growth (2016-2021)

5 Americas
5.1 Americas Peptide-based Drug Market Size by Country (2016-2021)
5.2 Americas Peptide-based Drug Market Size by Type (2016-2021)
5.3 Americas Peptide-based Drug Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Peptide-based Drug Market Size by Region (2016-2021)
6.2 APAC Peptide-based Drug Market Size by Type (2016-2021)
6.3 APAC Peptide-based Drug Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Peptide-based Drug by Country (2016-2021)
7.2 Europe Peptide-based Drug Market Size by Type (2016-2021)
7.3 Europe Peptide-based Drug Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Peptide-based Drug by Region (2016-2021)
8.2 Middle East & Africa Peptide-based Drug Market Size by Type (2016-2021)
8.3 Middle East & Africa Peptide-based Drug Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Peptide-based Drug Market Forecast
10.1 Global Peptide-based Drug Forecast by Regions (2021-2026)
10.1.1 Global Peptide-based Drug Forecast by Regions (2021-2026)
10.1.2 Americas Peptide-based Drug Forecast
10.1.3 APAC Peptide-based Drug Forecast
10.1.4 Europe Peptide-based Drug Forecast
10.1.5 Middle East & Africa Peptide-based Drug Forecast
10.2 Americas Peptide-based Drug Forecast by Countries (2021-2026)
10.2.1 United States Peptide-based Drug Market Forecast
10.2.2 Canada Peptide-based Drug Market Forecast
10.2.3 Mexico Peptide-based Drug Market Forecast
10.2.4 Brazil Peptide-based Drug Market Forecast
10.3 APAC Peptide-based Drug Forecast by Region (2021-2026)
10.3.1 China Peptide-based Drug Market Forecast
10.3.2 Japan Peptide-based Drug Market Forecast
10.3.3 Korea Peptide-based Drug Market Forecast
10.3.4 Southeast Asia Peptide-based Drug Market Forecast
10.3.5 India Peptide-based Drug Market Forecast
10.3.6 Australia Peptide-based Drug Market Forecast
10.4 Europe Peptide-based Drug Forecast by Country (2021-2026)
10.4.1 Germany Peptide-based Drug Market Forecast
10.4.2 France Peptide-based Drug Market Forecast
10.4.3 UK Peptide-based Drug Market Forecast
10.4.4 Italy Peptide-based Drug Market Forecast
10.4.5 Russia Peptide-based Drug Market Forecast
10.5 Middle East & Africa Peptide-based Drug Forecast by Region (2021-2026)
10.5.1 Egypt Peptide-based Drug Market Forecast
10.5.2 South Africa Peptide-based Drug Market Forecast
10.5.3 Israel Peptide-based Drug Market Forecast
10.5.4 Turkey Peptide-based Drug Market Forecast
10.5.5 GCC Countries Peptide-based Drug Market Forecast
10.6 Global Peptide-based Drug Forecast by Type (2021-2026)
10.7 Global Peptide-based Drug Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Peptide-based Drug Product Offered
11.1.3 Sanofi Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Peptide-based Drug Product Offered
11.2.3 Teva Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Peptide-based Drug Product Offered
11.3.3 Novo Nordisk Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Peptide-based Drug Product Offered
11.4.3 Takeda Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Peptide-based Drug Product Offered
11.5.3 Eli Lilly Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Peptide-based Drug Product Offered
11.6.3 AstraZeneca Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Peptide-based Drug Product Offered
11.7.3 Novartis Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Peptide-based Drug Product Offered
11.8.3 AbbVie Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Peptide-based Drug Product Offered
11.9.3 Ipsen Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Peptide-based Drug Product Offered
11.10.3 Ferring Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11. Merck
11.11.1 Merck Company Information
11.11.2 Merck Peptide-based Drug Product Offered
11.11.3 Merck Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Peptide-based Drug Product Offered
11.12.3 The Medicines Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Peptide-based Drug Product Offered
11.13.3 J & J Peptide-based Drug Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Peptide-based Drug Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Injection
Table 3. Major Players of Oral
Table 4. Major Players of Other
Table 5. Peptide-based Drug Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Peptide-based Drug Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Peptide-based Drug Market Size Market Share by Type (2016-2021)
Table 8. Peptide-based Drug Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Peptide-based Drug Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Peptide-based Drug Market Size Market Share by Application (2016-2021)
Table 11. Global Peptide-based Drug Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Peptide-based Drug Revenue Market Share by Players (2019-2021E)
Table 13. Peptide-based Drug Key Players Head office and Products Offered
Table 14. Peptide-based Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peptide-based Drug Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Peptide-based Drug Market Size Market Share by Regions 2016-2021
Table 19. Americas Peptide-based Drug Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Peptide-based Drug Market Size Market Share by Country (2016-2021)
Table 21. Americas Peptide-based Drug Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Peptide-based Drug Market Size Market Share by Type (2016-2021)
Table 23. Americas Peptide-based Drug Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Peptide-based Drug Market Size Market Share by Application (2016-2021)
Table 25. APAC Peptide-based Drug Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Peptide-based Drug Market Size Market Share by Region (2016-2021)
Table 27. APAC Peptide-based Drug Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Peptide-based Drug Market Size Market Share by Type (2016-2021)
Table 29. APAC Peptide-based Drug Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Peptide-based Drug Market Size Market Share by Application (2016-2021)
Table 31. Europe Peptide-based Drug Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Peptide-based Drug Market Size Market Share by Country (2016-2021)
Table 33. Europe Peptide-based Drug Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Peptide-based Drug Market Size Market Share by Type (2016-2021)
Table 35. Europe Peptide-based Drug Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Peptide-based Drug Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Peptide-based Drug Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Peptide-based Drug Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Peptide-based Drug Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Peptide-based Drug Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Peptide-based Drug Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Peptide-based Drug Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Peptide-based Drug
Table 44. Key Application and Potential Industries of Peptide-based Drug
Table 45. Key Challenges of Peptide-based Drug
Table 46. Key Trends of Peptide-based Drug
Table 47. Global Peptide-based Drug Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Peptide-based Drug Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Peptide-based Drug Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Peptide-based Drug Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Peptide-based Drug Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Peptide-based Drug Market Size Market Share Forecast by Application (2021-2026)
Table 53. Sanofi Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 54. Sanofi Peptide-based Drug Product Offered
Table 55. Sanofi Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Teva Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 59. Teva Peptide-based Drug Product Offered
Table 60. Teva Main Business
Table 61. Teva Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Teva Latest Developments
Table 63. Novo Nordisk Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 64. Novo Nordisk Peptide-based Drug Product Offered
Table 65. Novo Nordisk Main Business
Table 66. Novo Nordisk Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Novo Nordisk Latest Developments
Table 68. Takeda Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 69. Takeda Peptide-based Drug Product Offered
Table 70. Takeda Main Business
Table 71. Takeda Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Takeda Latest Developments
Table 73. Eli Lilly Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 74. Eli Lilly Peptide-based Drug Product Offered
Table 75. Eli Lilly Main Business
Table 76. Eli Lilly Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Eli Lilly Latest Developments
Table 78. AstraZeneca Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 79. AstraZeneca Peptide-based Drug Product Offered
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. AstraZeneca Latest Developments
Table 83. Novartis Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 84. Novartis Peptide-based Drug Product Offered
Table 85. Novartis Main Business
Table 86. Novartis Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Novartis Latest Developments
Table 88. AbbVie Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 89. AbbVie Peptide-based Drug Product Offered
Table 90. AbbVie Main Business
Table 91. AbbVie Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. AbbVie Latest Developments
Table 93. Ipsen Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 94. Ipsen Peptide-based Drug Product Offered
Table 95. Ipsen Main Business
Table 96. Ipsen Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Ipsen Latest Developments
Table 98. Ferring Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 99. Ferring Peptide-based Drug Product Offered
Table 100. Ferring Main Business
Table 101. Ferring Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Ferring Latest Developments
Table 103. Merck Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 104. Merck Peptide-based Drug Product Offered
Table 105. Merck Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. The Medicines Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 109. The Medicines Peptide-based Drug Product Offered
Table 110. The Medicines Main Business
Table 111. The Medicines Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. The Medicines Latest Developments
Table 113. J & J Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 114. J & J Peptide-based Drug Product Offered
Table 115. J & J Main Business
Table 116. J & J Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. J & J Latest Developments
List of Figures
Figure 1. Peptide-based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide-based Drug Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Peptide-based Drug Market Size Market Share by Type in 2020
Figure 7. Peptide-based Drug in Cancer
Figure 8. Global Peptide-based Drug Market: Cancer (2016-2021) & ($ Millions)
Figure 9. Peptide-based Drug in Metabolic Disorders
Figure 10. Global Peptide-based Drug Market: Metabolic Disorders (2016-2021) & ($ Millions)
Figure 11. Peptide-based Drug in Central Nervous System
Figure 12. Global Peptide-based Drug Market: Central Nervous System (2016-2021) & ($ Millions)
Figure 13. Peptide-based Drug in Other
Figure 14. Global Peptide-based Drug Market: Other (2016-2021) & ($ Millions)
Figure 15. Global Peptide-based Drug Market Size Market Share by Application in 2020
Figure 16. Global Peptide-based Drug Revenue Market Share by Player in 2020
Figure 17. Global Peptide-based Drug Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Peptide-based Drug Market Size 2016-2021 ($ Millions)
Figure 19. APAC Peptide-based Drug Market Size 2016-2021 ($ Millions)
Figure 20. Europe Peptide-based Drug Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Peptide-based Drug Market Size 2016-2021 ($ Millions)
Figure 22. Americas Peptide-based Drug Market Size Market Share by Country in 2020
Figure 23. Americas Peptide-based Drug Market Size Market Share by Type in 2020
Figure 24. Americas Peptide-based Drug Market Size Market Share by Application in 2020
Figure 25. United States Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Peptide-based Drug Market Size Market Share by Regions in 2020
Figure 29. APAC Peptide-based Drug Market Size Market Share by Type in 2020
Figure 30. APAC Peptide-based Drug Market Size Market Share by Application in 2020
Figure 31. China Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Peptide-based Drug Market Size Market Share by Country in 2020
Figure 38. Europe Peptide-based Drug Market Size Market Share by Type in 2020
Figure 39. Europe Peptide-based Drug Market Size Market Share by Application in 2020
Figure 40. Germany Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Peptide-based Drug Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Peptide-based Drug Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Peptide-based Drug Market Size Market Share by Application in 2020
Figure 48. Egypt Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Peptide-based Drug Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 54. APAC Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 55. Europe Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 57. United States Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 58. Canada Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 61. China Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 62. Japan Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 63. Korea Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 65. India Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 66. Australia Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 67. Germany Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 68. France Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 69. UK Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 70. Italy Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 71. Russia Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 72. Spain Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 75. Israel Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Peptide-based Drug Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Peptide-based Drug Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 펩타이드 기반 약물 시장예측 2021년-2026년] (코드 : LPI-2201K02139) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 펩타이드 기반 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 펩타이드 치료제 시장예측 2021년-2026년
LPI-2201K02265 / LP Information / 2021년 12월 / 본 조사보고서는 펩타이드 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Peptide Therapeutics will have significant change from previous year. By the most conservative estimates of global Peptide Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 31480 million in 2020. Over...

세계의 펩타이드 CDMO 시장예측 2021년-2026년
LPI-2201K02264 / LP Information / 2021년 12월 / 본 조사보고서는 펩타이드 CDMO의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Peptide CDMO will have significant change from previous year. By the most conservative estimates of global Peptide CDMO market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 녹두 펩타이드 시장예측 2021년-2026년
LPI-2201K02926 / LP Information / 2021년 12월 / 본 조사보고서는 녹두 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Mung Bean Peptide will have significant change from previous year. By the most conservative estimates of global Mung Bean Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 모모르디카 카란티아 펩타이드 시장예측 2021년-2026년
LPI-2201K02908 / LP Information / 2021년 12월 / 본 조사보고서는 모모르디카 카란티아 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Momordica Charantia Peptide will have significant change from previous year. By the most conservative estimates of global Momordica Charantia Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 대두 펩타이드 시장예측 2021년-2026년
LPI-2201K03523 / LP Information / 2021년 12월 / 본 조사보고서는 대두 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Soybean Peptide will have significant change from previous year. By the most conservative estimates of global Soybean Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 완두콩 펩타이드 시장예측 2021년-2026년
LPI-2201K03103 / LP Information / 2021년 12월 / 본 조사보고서는 완두콩 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pea Peptide will have significant change from previous year. By the most conservative estimates of global Pea Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 밀 펩타이드 시장예측 2021년-2026년
LPI-2201K03795 / LP Information / 2021년 12월 / 본 조사보고서는 밀 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Wheat Peptide will have significant change from previous year. By the most conservative estimates of global Wheat Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...